A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays

Virology

Volumn 397, Issue 2, 2010, Pages 346-357

  Kraus, Matthias H ^a   Parrish, Nicholas F ^a   Shaw, Katharina S ^a   Decker, Julie M ^a   Keele, Brandon F ^a   Salazar Gonzalez, Jesus F ^a   Grayson, Truman ^a   McPherson, David T ^a   Ping, Li Hua ^b   Anderson, Jeffrey A ^b   Swanstrom, Ronald ^b   Williamson, Carolyn ^c   Shaw, George M ^a   Hahn, Beatrice H ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d University of Alabama at Birmingham   (United States)

Author keywords

Env pseudotyping; HIV 1 Env expression; HIV 1 gene arrangement; HIV 1 subtype A; HIV 1 subtype C

Indexed keywords

DNA POLYMERASE REV1; GLYCOPROTEIN GP 120; VIRUS ENVELOPE PROTEIN; VPU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; EXON; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE CASSETTE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOTYPING; SEQUENCE ANALYSIS; STOP CODON; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS MUTATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 75749131917     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.019     Document Type: Article

References (48)

1. Abrahams M.R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.H., Athreya G.S., Treurnicht F.K., Keele B.F., Wood N., Salazar-Gonzalez J.F., Bhattacharya T., Chu H., Hoffman I., Galvin S., Mapanje C., Kazembe P., Thebus R., Fiscus S., Hide W., Cohen M.S., Karim S.A., Haynes B.F., Shaw G.M., Hahn B.H., Korber B.T., Swanstrom R., and Williamson C. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 83 (2009) 3556-3567
2. Anderson J.L., Johnson A.T., Howard J.L., and Purcell D.F. Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs. J. Virol. 81 (2007) 4664-4676
3. Asang C., Hauber I., and Schaal H. Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res. 36 (2008) 1450-1463
4. Beddows S., Schulke N., Kirschner M., Barnes K., Franti M., Michael E., Ketas T., Sanders R.W., Maddon P.J., Olson W.C., and Moore J.P. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 79 (2005) 8812-8827
5. Beels D., Heyndrickx L., Vereecken K., Vermoesen T., Michiels L., Vanham G., and Kestens L. Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes. J. Virol. Methods 147 (2008) 99-107
6. Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., Stiegler G., Kunert R., Zolla-Pazner S., Katinger H., Petropoulos C.J., and Burton D.R. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78 (2004) 13232-13252
7. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
8. Freund M., Asang C., Kammler S., Konermann C., Krummheuer J., Hipp M., Meyer I., Gierling W., Theiss S., Preuss T., Schindler D., Kjems J., and Schaal H. A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res. 31 (2003) 6963-6975
9. Gale Jr. M., Tan S.L., and Katze M.G. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64 (2000) 239-280
10. Gao F., Morrison S.G., Robertson D.L., Thornton C.L., Craig S., Karlsson G., Sodroski J., Morgado M., Galvao-Castro B., von Briesen H., Beddows S., Weber J., Sharp P.M., Shaw G.M., and Hahn B.H. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J. Virol. 70 (1996) 1651-1667
11. Goodenow M., Huet T., Saurin W., Kwok S., Sninsky J., and Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. Acquir. Immune Defic. Syndr. 2 (1989) 344-352
12. Hammarskjold M.L., Heimer J., Hammarskjold B., Sangwan I., Albert L., and Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63 (1989) 1959-1966
13. Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., and Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64 (1990) 2416-2420
14. Isaacman-Beck J., Hermann E.A., Yi Y., Ratcliffe S.J., Mulenga J., Allen S., Hunter E., Derdeyn C.A., and Collman R.G. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 83 (2009) 8208-8220
15. Kammler S., Leurs C., Freund M., Krummheuer J., Seidel K., Tange T.O., Lund M.K., Kjems J., Scheid A., and Schaal H. The sequence complementarity between HIV-1 5′ splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA 7 (2001) 421-434
16. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., and Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 7552-7557
17. Keele B.F., Li H., Learn G.H., Hraber P., Giorgi E.E., Grayson T., Sun C., Chen Y., Yeh W.W., Letvin N.L., Mascola J.R., Nabel G.J., Haynes B.F., Bhattacharya T., Perelson A.S., Korber B.T., Hahn B.H., and Shaw G.M. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206 (2009) 1117-1134
18. Kirchherr J.L., Lu X., Kasongo W., Chalwe V., Mwananyanda L., Musonda R.M., Xia S.M., Scearce R.M., Liao H.X., Montefiori D.C., Haynes B.F., and Gao F. High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143 (2007) 104-111
19. Kozak M. Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Mol. Cell Biol. 7 (1987) 3438-3445
20. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 234 (1999) 187-208
21. Krummheuer J., Johnson A.T., Hauber I., Kammler S., Anderson J.L., Hauber J., Purcell D.F., and Schaal H. A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG. Virology 363 (2007) 261-271
22. Kwong P.D., and Wilson I.A. HIV-1 and influenza antibodies: seeing antigens in new ways. Nat. Immunol. 10 (2009) 573-578
23. Lee H.Y., Giorgi E.E., Keele B.F., Gaschen B., Athreya G.S., Salazar-Gonzalez J.F., Pham K.T., Goepfert P.A., Michael Kilby J., Saag M.S., Delwart E.L., Busch M.P., Hahn B.H., Shaw G.M., Korber B.T., Bhattacharya T., and Perelson A.S. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261 (2009) 341-360
24. Li M., Gao F., Mascola J.R., Stamatatos L., Polonis V.R., Koutsoukos M., Voss G., Goepfert P., Gilbert P., Greene K.M., Bilska M., Kothe D.L., Salazar-Gonzalez J.F., Wei X., Decker J.M., Hahn B.H., and Montefiori D.C. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79 (2005) 10108-10125
25. Li M., Salazar-Gonzalez J.F., Derdeyn C.A., Morris L., Williamson C., Robinson J.E., Decker J.M., Li Y., Salazar M.G., Polonis V.R., Mlisana K., Karim S.A., Hong K., Greene K.M., Bilska M., Zhou J., Allen S., Chomba E., Mulenga J., Vwalika C., Gao F., Zhang M., Korber B.T., Hunter E., Hahn B.H., and Montefiori D.C. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80 (2006) 11776-11790
26. Lu X.B., Heimer J., Rekosh D., and Hammarskjold M.L. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 7598-7602
27. Luukkonen B.G., Tan W., and Schwartz S. Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance. J. Virol. 69 (1995) 4086-4094
28. Malim M.H., and Emerman M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3 (2008) 388-398
29. Malim M.H., Hauber J., Fenrick R., and Cullen B.R. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335 (1988) 181-183
30. Mascola J.R., D'Souza P., Gilbert P., Hahn B.H., Haigwood N.L., Morris L., Petropoulos C.J., Polonis V.R., Sarzotti M., and Montefiori D.C. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J. Virol. 79 (2005) 10103-10107
31. Montefiori D., Sattentau Q., Flores J., Esparza J., and Mascola J. Antibody-based HIV-1 vaccines: recent developments and future directions. PLoS Med 4 (2007) e348
32. Munoz J.L., Parks W.P., Wolinsky S.M., Korber B.T., and Hutto C. HIV-1 reverse transcriptase. A diversity generator and quasispecies regulator. Ann. N.Y. Acad. Sci. 693 (1993) 65-70
33. Nedellec R., Coetzer M., Shimizu N., Hoshino H., Polonis V.R., Morris L., Martensson U.E., Binley J., Overbaugh J., and Mosier D.E. Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J. Virol. 83 (2009) 8353-8363
34. Ochsenbauer-Jambor C., Ding H., Keele B.F., Salazar-Gonzalez J., Edmonds T.G., Shattock R., Clapham P., Shaw G.M., Hahn B.H., and Kappes J.C. Generation and biological characterization of infectious molecular clones derived from Clade B HIV-1 transmitted/founder viruses Conference on Retroviruses and Opportunistic Infections (2009), Montreal, Quebec
35. Palmer S., Kearney M., Maldarelli F., Halvas E.K., Bixby C.J., Bazmi H., Rock D., Falloon J., Davey Jr. R.T., Dewar R.L., Metcalf J.A., Hammer S., Mellors J.W., and Coffin J.M. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin. Microbiol. 43 (2005) 406-413
36. Provine N.M., Puryear W.B., Wu X., Overbaugh J., and Haigwood N.L. The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity. J. Virol. 83 (2009) 9002-9007
37. Purcell D.F., and Martin M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67 (1993) 6365-6378
38. Richman D.D., Wrin T., Little S.J., and Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4144-4149
39. Salazar-Gonzalez J.F., Bailes E., Pham K.T., Salazar M.G., Guffey M.B., Keele B.F., Derdeyn C.A., Farmer P., Hunter E., Allen S., Manigart O., Mulenga J., Anderson J.A., Swanstrom R., Haynes B.F., Athreya G.S., Korber B.T., Sharp P.M., Shaw G.M., and Hahn B.H. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82 (2008) 3952-3970
40. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., Decker J.M., Wang S., Baalwa J., Kraus M.H., Parrish N.F., Shaw K.S., Guffey M.B., Bar K.J., Davis K.L., Ochsenbauer-Jambor C., Kappes J.C., Saag M.S., Cohen M.S., Mulenga J., Derdeyn C.A., Allen S., Hunter E., Markowitz M., Hraber P., Perelson A.S., Bhattacharya T., Haynes B.F., Korber B.T., Hahn B.H., and Shaw G.M. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206 (2009) 1273-1289
41. Schwartz S., Felber B.K., Fenyo E.M., and Pavlakis G.N. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64 (1990) 5448-5456
42. Shriner D., Rodrigo A.G., Nickle D.C., and Mullins J.I. Pervasive genomic recombination of HIV-1 in vivo. Genetics 167 (2004) 1573-1583
43. Takehisa J., Kraus M.H., Decker J.M., Li Y., Keele B.F., Bibollet-Ruche F., Zammit K.P., Weng Z., Santiago M.L., Kamenya S., Wilson M.L., Pusey A.E., Bailes E., Sharp P.M., Shaw G.M., and Hahn B.H. Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. J. Virol. 81 (2007) 7463-7475
44. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., and Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46 (2002) 1896-1905
45. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., and Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 422 (2003) 307-312
46. Whitcomb J.M., Huang W., Fransen S., Limoli K., Toma J., Wrin T., Chappey C., Kiss L.D., Paxinos E.E., and Petropoulos C.J. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob. Agents Chemother. 51 (2007) 566-575
47. Wyatt R., and Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 (1998) 1884-1888
48. Zwick M.B., and Burton D.R. HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr. HIV Res. 5 (2007) 608-624